1. Home
  2. ITRM vs OCFCP Comparison

ITRM vs OCFCP Comparison

Compare ITRM & OCFCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • OCFCP
  • Stock Information
  • Founded
  • ITRM 2015
  • OCFCP N/A
  • Country
  • ITRM Ireland
  • OCFCP United States
  • Employees
  • ITRM N/A
  • OCFCP 1007
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • OCFCP Major Banks
  • Sector
  • ITRM Health Care
  • OCFCP Finance
  • Exchange
  • ITRM Nasdaq
  • OCFCP Nasdaq
  • Market Cap
  • ITRM 37.7M
  • OCFCP N/A
  • IPO Year
  • ITRM 2018
  • OCFCP N/A
  • Fundamental
  • Price
  • ITRM $1.22
  • OCFCP $25.35
  • Analyst Decision
  • ITRM Strong Buy
  • OCFCP
  • Analyst Count
  • ITRM 1
  • OCFCP 0
  • Target Price
  • ITRM $5.00
  • OCFCP N/A
  • AVG Volume (30 Days)
  • ITRM 322.6K
  • OCFCP N/A
  • Earning Date
  • ITRM 05-12-2025
  • OCFCP N/A
  • Dividend Yield
  • ITRM N/A
  • OCFCP N/A
  • EPS Growth
  • ITRM N/A
  • OCFCP N/A
  • EPS
  • ITRM N/A
  • OCFCP N/A
  • Revenue
  • ITRM N/A
  • OCFCP N/A
  • Revenue This Year
  • ITRM N/A
  • OCFCP N/A
  • Revenue Next Year
  • ITRM $150.10
  • OCFCP N/A
  • P/E Ratio
  • ITRM N/A
  • OCFCP N/A
  • Revenue Growth
  • ITRM N/A
  • OCFCP N/A
  • 52 Week Low
  • ITRM $0.81
  • OCFCP N/A
  • 52 Week High
  • ITRM $3.02
  • OCFCP N/A
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 51.88
  • OCFCP 60.16
  • Support Level
  • ITRM $1.01
  • OCFCP $25.24
  • Resistance Level
  • ITRM $1.16
  • OCFCP $25.36
  • Average True Range (ATR)
  • ITRM 0.08
  • OCFCP 0.04
  • MACD
  • ITRM 0.01
  • OCFCP 0.00
  • Stochastic Oscillator
  • ITRM 80.73
  • OCFCP 93.06

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About OCFCP OceanFirst Financial Corp. Depositary Shares

OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.

Share on Social Networks: